IP Library Granted Patent US 7,834,190
Granted Patent B2
US 7,834,190 · App. 12/227,788 · Granted Nov 16, 2010

Process for production of optically active-3-amino-2-hydroxypropionic cyclopropylamide derivatives and salts thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,834,190
App. No.
12/227,788
Granted
Nov 16, 2010
Kind
B2
Abstract

An objective of the present application is to provide an industrially practicable method for producing an optically-active 3-amino-2-hydroxypropionic cyclopropylamide derivative or salt thereof from an inexpensive easily-available starting material. The derivative or salt thereof is useful as an intermediate for a medicine. It is also intended by the present application to provide a useful intermediate of the derivative. The objective is attained by the following method. First, an easily-available 2-halo-3-oxopropionic acid derivative is asymmetrically reduced, and then epoxidated to produce an optically-active epoxycarboxylic acid derivative. Next, the derivative is converted into an optically-active epoxyamide derivative by reaction with cyclopropylamine, and then reacted with a nitrile to obtain an optically-active oxazolinamide derivative. Subsequently, selective acid solvolysis of the oxazoline skeleton gives the optically-active 3-amino-2-hydroxypropionic cyclopropylamide derivative or salt thereof.

Claims (55)

1. An optically-active oxazolinamide derivative represented by the following formula (1):

wherein, * indicates an asymmetric carbon atom; R 1 represents an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, an alkenyl group having 2 to 20 carbon atoms and optionally having a substituent, an aryl group having 6 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent; R 4 represents an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent.

2. An optically-active oxazoline carboxylic acid derivative represented by the following formula (5):

wherein, * indicates an asymmetric carbon atom; R 1 represents an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, an alkenyl group having 2 to 20 carbon atoms and optionally having a substituent, an aryl group having 6 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent; R 2 represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, an alkenyl group having 2 to 20 carbon atoms and optionally having a substituent, an aryl group having 6 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent; R 4 represents an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent.

3. A compound represented by the following formula (17):

wherein, * indicates an asymmetric carbon atom; R 1 represents an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, an alkenyl group having 2 to 20 carbon atoms and optionally having a substituent, an aryl group having 6 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent; R 4 represents an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent.

4. A method for producing an optically-active 2-halo-3-hydroxypropionic acid derivative;

comprising a step of asymmetric reduction of a 2-halo-3-oxopropionic acid derivative represented by the following formula (10):

wherein, R 2 represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, an alkenyl group having 2 to 20 carbon atoms and optionally having a substituent, an aryl group having 6 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent; X represents a halogen atom; R 4 represents an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent;

wherein the optically-active 2-halo-3-hydroxypropionic acid derivative is represented by the following formula (11):

wherein, * indicates an asymmetric carbon atom; R 2 , R 4 and X are the same as above.

5. A method for producing an optically-active epoxyamide derivative;

comprising a step of reacting an optically-active epoxycarboxylic acid derivative represented by the following formula (7):

wherein, * indicates an asymmetric carbon atom; R 2 represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, an alkenyl group having 2 to 20 carbon atoms and optionally having a substituent, an aryl group having 6 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent; R 4 represents an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent

with a cyclopropylamine represented by the following formula (6):

wherein, the optically-active epoxyamide derivative is represented by the following formula (3):

wherein, * is the same as above; R 4 represents an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent.

6. The method for producing the optically-active epoxyamide derivative according to claim 5 ; wherein

the compound (7) wherein R 2 is a hydrogen atom is reacted with an alkoxycarbonyl chloride, a dialkyl dicarbonate or pivaloyl chloride in a presence of a base to obtain a mixed acid anhydride; and

the mixed acid anhydride is reacted with the cyclopropylamine of the formula (6).

7. A method for producing an optically-active oxazolinamide derivative;

comprising a step of reacting an optically-active epoxyamide derivative represented by the following formula (3):

wherein, * indicates an asymmetric carbon atom; R 4 represents an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent

with a nitrile represented by the following formula (4):

R 1 CN  (4)

wherein, R 1 represents an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, an alkenyl group having 2 to 20 carbon atoms and optionally having a substituent, an aryl group having 6 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent in a presence of an acid catalyst; and

wherein the optically-active oxazolinamide derivative is represented by the following formula (1):

wherein, *, R 1 and R 4 are the same as above.

8. The method for producing the optically-active oxazolinamide derivative according to claim 7 , wherein the compound (3) is obtained by a method comprising a step of reacting an optically-active epoxycarboxylic acid derivative represented by the following formula (7):

wherein, * and R 4 are the same as above; R 2 represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, an alkenyl group having 2 to 20 carbon atoms and optionally having a substituent, an aryl group having 6 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent

with a cyclopropylamine represented by the following formula (6):

9. A method for producing an optically-active oxazolinamide derivative;

comprising steps of reacting an optically-active epoxycarboxylic acid derivative represented by the following formula (7):

wherein, * indicates an asymmetric carbon atom; R 2 represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, an alkenyl group having 2 to 20 carbon atoms and optionally having a substituent, an aryl group having 6 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent; R 4 represents an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent

with a nitrile represented by the following formula (4):

R 1 CN  (4)

wherein R 1 represents an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, an alkenyl group having 2 to 20 carbon atoms and optionally having a substituent, an aryl group having 6 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent

in a presence of an acid catalyst to produce an optically-active oxazolinecarboxylic acid derivative represented by the following formula (5):

wherein, *, R 1 , R 2 and R 4 are the same as above; and

then reacting the optically-active oxazolinecarboxylic acid derivative with a cyclopropylamine represented by the following formula (6):

wherein the optically-active oxazolinamide derivative is represented by the following formula (1):

wherein, *, R 1 and R 4 are the same as above.

10. A method for producing an optically-active 3-amino-2-hydroxypropionic cyclopropylamide derivative or salt thereof;

comprising a step of selective acid hydrolysis or acid alcoholysis of an oxazoline ring of an optically-active oxazolinamide derivative represented by the following formula (1):

wherein, * indicates an asymmetric carbon atom; R 1 represents an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, an alkenyl group having 2 to 20 carbon atoms and optionally having a substituent, an aryl group having 6 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent; R 4 represents an alkyl group having 1 to 20 carbon atoms and optionally having a substituent, or an aralkyl group having 7 to 20 carbon atoms and optionally having a substituent;

wherein the optically-active 3-amino-2-hydroxypropionic cyclopropylamide derivative is represented by the following formula (2):

wherein, * and R 4 are the same as above.

11. The optically-active oxazolinamide derivative according to claim 1 , wherein R 4 is an n-propyl group.

12. The optically-active oxazoline carboxylic acid derivative according to claim 2 , wherein R 4 is an n-propyl group.

13. The compound according to claim 3 , wherein R 4 is an n-propyl group.

14. The method according to claim 4 , wherein R 4 is an n-propyl group.

15. The method according to claim 5 , wherein R 4 is an n-propyl group.

16. The method according to claim 7 , wherein R 4 is an n-propyl group.

17. The method according to claim 9 , wherein R 4 is an n-propyl group.

18. The method according to claim 10 , wherein R 4 is an n-propyl group.

Assignments (2)
CHANGE OF ADDRESS Recorded Jan 15, 2014
From: KANEKA CORPORATION
To: KANEKA CORPORATION
Reel/Frame 032019/0901 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2008
From: MORI, KOHEI; NISHIYAMA, AKIRA; TAOKA, NAOAKI; MORIYAMA, DAISUKE; NAGASHIMA, NOBUO
To: KANEKA CORPORATION
Reel/Frame 021918/0861 →